We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Flawed arithmetic on drug development costs.
- Authors
Subbaraman, Nidhi
- Abstract
The article discusses a study by researchers Donald W. Light and Rebecca Warburton on the median cost of developing drugs. The study which estimated median drug development cost to be as low as 59 million U.S. dollars has raised concerns. Critics argue that the researchers made the wrong assumption that clinical trial and regulatory review times are declining as well as underestimated the attrition rates and risks of drug discovery. The researchers contend that their estimate excludes the cost of discovery.
- Subjects
DRUG development; COST; CLINICAL trials; ATTRITION in research studies; LIGHT, Donald W.; WARBURTON, Rebecca
- Publication
Nature Biotechnology, 2011, Vol 29, Issue 5, p381
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0511-381a